Treatment-resistant psychotic symptoms and the 15q11.2 BP1–BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature

[1]  M. Owen,et al.  Increasing the Clinical Psychiatric Knowledge Base About Pathogenic Copy Number Variation. , 2020, The American journal of psychiatry.

[2]  P. Sullivan,et al.  M94 THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA , 2019, European Neuropsychopharmacology.

[3]  J. R. MacDonald,et al.  A large data resource of genomic copy number variation across neurodevelopmental disorders , 2019, npj Genomic Medicine.

[4]  J. Sebat,et al.  Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene , 2019, Biological Psychiatry.

[5]  A. Amorim,et al.  Essential genetic findings in neurodevelopmental disorders , 2019, Human Genomics.

[6]  M. Butler.  Magnesium Supplement and the 15q11.2 BP1–BP2 Microdeletion (Burnside–Butler) Syndrome: A Potential Treatment? , 2019, International journal of molecular sciences.

[7]  H. Stefánsson,et al.  Reciprocal White Matter Changes Associated With Copy Number Variation at 15q11.2 BP1-BP2: A Diffusion Tensor Imaging Study , 2019, Biological Psychiatry.

[8]  H. Mandel,et al.  De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies. , 2019, American journal of human genetics.

[9]  B. Kinon.  The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS) , 2019, Front. Psychiatry.

[10]  Caroline F. Wright,et al.  Common genetic variants contribute to risk of rare severe neurodevelopmental disorders , 2018, Nature.

[11]  P. Sullivan,et al.  Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease. , 2018, The American journal of psychiatry.

[12]  J. Vermeesch,et al.  Neurodevelopmental risk copy number variants in adults with intellectual disabilities and comorbid psychiatric disorders , 2018, British Journal of Psychiatry.

[13]  P. Stankiewicz,et al.  An estimation of the prevalence of genomic disorders using chromosomal microarray data , 2018, Journal of Human Genetics.

[14]  J. Friedman,et al.  Copy Number Variation in Syndromic Forms of Psychiatric Illness: The Emerging Value of Clinical Genetic Testing in Psychiatry. , 2017, The American journal of psychiatry.

[15]  M. Owen,et al.  Schizophrenia and the neurodevelopmental continuum:evidence from genomics , 2017, World psychiatry : official journal of the World Psychiatric Association.

[16]  A. Bassett,et al.  Genomic Disorders in Psychiatry—What Does the Clinician Need to Know? , 2017, Current Psychiatry Reports.

[17]  M. Butler,et al.  Clinical and genetic aspects of the 15q11.2 BP1–BP2 microdeletion disorder , 2017, Journal of intellectual disability research : JIDR.

[18]  D Brandeis,et al.  15q11.2 CNV affects cognitive, structural and functional correlates of dyslexia and dyscalculia , 2017, Translational Psychiatry.

[19]  M. Itokawa,et al.  High-resolution copy number variation analysis of schizophrenia in Japan , 2017, Molecular Psychiatry.

[20]  A. Prasad,et al.  Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders , 2016, International journal of molecular sciences.

[21]  Wei Cheng,et al.  Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects , 2016, Nature Genetics.

[22]  D. Collier,et al.  Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia. , 2016, JAMA psychiatry.

[23]  M. Krebs,et al.  Paradoxical Improvement of Schizophrenic Symptoms by a Dopaminergic Agonist: An Example of Personalized Psychiatry in a Copy Number Variation–Carrying Patient , 2016, Biological Psychiatry.

[24]  B. Abrahams,et al.  Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks , 2016, PloS one.

[25]  U. Surti,et al.  Genetic and Morphological Features of Human iPSC-Derived Neurons with Chromosome 15q11.2 (BP1-BP2) Deletions , 2015, Molecular Neuropsychiatry.

[26]  M. Butler,et al.  The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review , 2015, International journal of molecular sciences.

[27]  G. Kirov,et al.  The Penetrance of Copy Number Variations for Schizophrenia and Developmental Delay , 2014, Biological Psychiatry.

[28]  Adam J. Schwarz,et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls , 2013, Nature.

[29]  David W. Evans,et al.  Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence , 2013, The Lancet Neurology.

[30]  Donna M. Martin,et al.  Phenotypic heterogeneity of genomic disorders and rare copy-number variants. , 2012, The New England journal of medicine.

[31]  S. Schwartz,et al.  Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay , 2011, Human Genetics.

[32]  Terry L. Jernigan,et al.  The Basics of Brain Development , 2010, Neuropsychology Review.

[33]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[34]  S. Mccarroll,et al.  Copy-number variation and association studies of human disease , 2007, Nature Genetics.

[35]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[36]  Kenny Q. Ye,et al.  Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.

[37]  R. Bajcsy,et al.  A method for obtaining 3-dimensional facial expressions and its standardization for use in neurocognitive studies , 2002, Journal of Neuroscience Methods.

[38]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.

[39]  R. Murray,et al.  Is schizophrenia a neurodevelopmental disorder? , 1987, British medical journal.

[40]  D. Weinberger.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.

[41]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[42]  J. Stiles.  Brain development and the nature versus nurture debate. , 2011, Progress in brain research.

[43]  D. Wechsler.  Manual of the Wechsler Intelligence Scale for Children-Revised , 1974 .

[44]  D. Wechsler.  Manual for the Wechsler Adult Intelligence Scale. , 1955 .